Longitude Venture Partners L.p. - Net Worth and Insider Trading
Longitude Venture Partners L.p. Net Worth
The estimated net worth of Longitude Venture Partners L.p. is at least $593 Million dollars as of 2024-09-20. Longitude Venture Partners L.p. is the 10% Owner of Corcept Therapeutics Inc and owns about 13,956,002 shares of Corcept Therapeutics Inc (CORT) stock worth over $593 Million. Details can be seen in Longitude Venture Partners L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Longitude Venture Partners L.p. has not made any transactions after 2016-11-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Longitude Venture Partners L.p.
Longitude Venture Partners L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Longitude Venture Partners L.p. owns 3 companies in total, including Collegium Pharmaceutical Inc (COLL) , Corcept Therapeutics Inc (CORT) , and Esperion Therapeutics Inc (ESPR) .
Click here to see the complete history of Longitude Venture Partners L.p.’s form 4 insider trades.
Insider Ownership Summary of Longitude Venture Partners L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2015-05-06 | 10 percent owner |
| CORT | Corcept Therapeutics Inc | 2016-11-25 | director & 10 percent owner |
| ESPR | Esperion Therapeutics Inc | 2014-10-07 | 10 percent owner |
Longitude Venture Partners L.p. Latest Holdings Summary
Longitude Venture Partners L.p. currently owns a total of 1 stock. Longitude Venture Partners L.p. owns 13,956,002 shares of Corcept Therapeutics Inc (CORT) as of November 25, 2016, with a value of $593 Million.
Latest Holdings of Longitude Venture Partners L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2016-11-25 | 13,956,002 | 42.50 | 593,130,085 |
Holding Weightings of Longitude Venture Partners L.p.
Longitude Venture Partners L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Longitude Venture Partners L.p. has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the sale of 36,941 shares on November 25, 2016, which brought Longitude Venture Partners L.p. around $345,029.
Insider Trading History of Longitude Venture Partners L.p.
- 1
Longitude Venture Partners L.p. Trading Performance
GuruFocus tracks the stock performance after each of Longitude Venture Partners L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Longitude Venture Partners L.p. is 45.16%. GuruFocus also compares Longitude Venture Partners L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Longitude Venture Partners L.p. within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Longitude Venture Partners L.p.'s insider trading performs compared to the benchmark.
Performance of Longitude Venture Partners L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.61 | | | | | |
| Relative Return to S&P 500(%) | 11.29 | | | | | |
Longitude Venture Partners L.p. Ownership Network
Longitude Venture Partners L.p. Owned Company Details
What does Collegium Pharmaceutical Inc do?
Who are the key executives at Collegium Pharmaceutical Inc?
Longitude Venture Partners L.p. is the 10 percent owner of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP and General Counsel Shirley R. Kuhlmann , and EVP & Chief Financial Officer Tupper Colleen .
Collegium Pharmaceutical Inc (COLL) Insider Trades Summary
Over the past 18 months, Longitude Venture Partners L.p. made no insider transaction in Collegium Pharmaceutical Inc (COLL). Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 198,212 shares made by Joseph Ciaffoni , a net sale of 88,809 shares made by Shirley R. Kuhlmann , and a net sale of 141,576 shares made by Scott Dreyer .
In summary, during the past 3 months, insiders sold 29,818 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 29,818 shares. During the past 18 months, 486,885 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,885 shares.
Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Collegium Pharmaceutical Inc Insider Transactions
Longitude Venture Partners L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Longitude Venture Partners L.p.. You might contact Longitude Venture Partners L.p. via mailing address: 800 El Camino Real, Suite 220, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
